South West drug information and training, Bristol; *University of West of England, Bristol; Cheltenham General hospital, Cheltenham
|
Introduction There are many forces of change currently acting on hospital pharmacy practice. The desires to improve clinical effectiveness, utilise new technologies and manage manpower shortages have generated much interest in the evaluation of existing and innovative pharmacy services. Effective comparisons of these services are difficult to perform, as they need to be comprehensive, representative, free from personal bias and independent of compounding factors. The understanding and co-operation of multidisciplinary staff is usually required and disruption to patients must be minimised and justified.
Method The dispensary supply function at Cheltenham general hospital was defined by three flow charts: outpatient supply (OP), discharge supply (TTO) and non-stock inpatient supply (IP).
The software package, Promodel, was used to create a model of the dispensary supply process from these data and estimates. |
Focal points
|
Results A representative simulation of a hospital pharmacy dispensary has been created using discrete event simulation software. Comprehensive statistical summaries of the supply processes have been produced that detail mean patient-waiting times, maximal capacity of the system and per cent utilisation of staff.
Discussion The model is currently being validated by comparing predicted supply times for IP, OP and TTO prescriptions with actual supply times as determined by the hospital computer tracking system.
Once validated, the model will be used to investigate a multitude of organisational changes, eg, staffing numbers and skill-mix issues, process reorganisations, and alterations to service priorities. These investigations can be achieved in a rapid, comprehensive, objective manner with minimum disruption to the function of the department.
Although modelling software will not replace feasibility studies, the application of this technology provides a highly effective tool for health care managers. Its use can help to ensure that only the most promising, optimised services are selected for feasibility studies.
| 1. Smith F. Evaluation of pharmaceutical services: (1) Objectives, designs and frameworks. Int J Pharm Pract 1999;7: 113-27. |